Evidence map›Paper›PMID 31110352›Full record

ArticleNature genetics2019

Release of paused RNA polymerase II at specific loci favors DNA double-strand-break formation and promotes cancer translocations.

Gaetano Ivan Dellino, Fernando Palluzzi, Andrea Maria Chiariello, Rossana Piccioni, Simona Bianco, Laura Furia, Giulia De Conti, Britta A M Bouwman, Giorgio Melloni, Davide Guido and 7 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. To Break or Not to Break: The Role of TOP2B in Transcription.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Gaetano Ivan DellinoDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. gaetano.dellino@ieo.it.ORCID http://orcid.org/0000-0002-8673-4560
Fernando PalluzziDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Andrea Maria ChiarielloDepartment of Physics, University of Naples Federico II, and INFN Complesso di Monte Sant'Angelo, Naples, Italy.ORCID http://orcid.org/0000-0002-6112-0167
Rossana PiccioniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Simona BiancoDepartment of Physics, University of Naples Federico II, and INFN Complesso di Monte Sant'Angelo, Naples, Italy.ORCID http://orcid.org/0000-0001-5819-060X
Laura FuriaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Giulia De ContiDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0002-2647-228X
Britta A M BouwmanScience for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Giorgio MelloniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0001-6371-1334
Davide GuidoNeurology, Public Health and Disability Unit, Foundation IRCCS Neurological Institute Carlo Besta, Milan, Italy.
Luciano GiacòDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Lucilla LuziDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Davide CittaroCenter for Translational Genomics and Bioinformatics, IRCCS San Raffaele Hospital, Milan, Italy.ORCID http://orcid.org/0000-0003-0384-3700
Mario FarettaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Mario NicodemiDepartment of Physics, University of Naples Federico II, and INFN Complesso di Monte Sant'Angelo, Naples, Italy.
Nicola CrosettoScience for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3019-6978
Pier Giuseppe PelicciDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. piergiuseppe.pelicci@ieo.it.ORCID http://orcid.org/0000-0002-0927-8290
European Institute of Oncology · ITScience for Life Laboratory · SEUniversity of Naples Federico II · ITBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEFondazione IRCCS Istituto Neurologico Carlo Besta · ITHarvard University · USIstituto Ortopedico Gaetano Pini · ITUniversity of Milan · ITUniversity of Pavia · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is not clear how spontaneous DNA double-strand breaks (DSBs) form and are processed in normal cells, and whether they predispose to cancer-associated translocations. We show that DSBs in normal mammary cells form upon release of paused RNA polymerase II (Pol II) at promoters, 5' splice sites and active enhancers, and are processed by end-joining in the absence of a canonical DNA-damage response. Logistic and causal-association models showed that Pol II pausing at long genes is the main predictor and determinant of DSBs. Damaged introns with paused Pol II-pS5, TOP2B and XRCC4 are enriched in translocation breakpoints, and map at topologically associating domain boundary-flanking regions showing high interaction frequencies with distal loci. Thus, in unperturbed growth conditions, release of paused Pol II at specific loci and chromatin territories favors DSB formation, leading to chromosomal translocations.

Indexed as

DNA Breaks, Double-StrandedGenetic LociAnimalsCell Line, TumorCells, CulturedDNA RepairEnhancer Elements, GeneticEtoposideFlow CytometryFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticGenomicsIntronsNeoplasmsPromoter Regions, GeneticRNA Polymerase IIEtoposideRNA Polymerase IIRNA Splice SitesTopoisomerase Inhibitors

Identifiers

PMID31110352
OpenAlexW2944903436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.